The Rate of Increase of Short Telomeres Predicts Longevity in Mammals

Slides:



Advertisements
Similar presentations
Irreplaceability of Neuronal Ensembles after Memory Allocation Naoki Matsuo Cell Reports Volume 11, Issue 3, Pages (April 2015) DOI: /j.celrep
Advertisements

Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer by Bruno Bernardes de Jesus, Elsa Vera, Kerstin.
Volume 66, Issue 4, Pages (October 2004)
Mary Armanios, Jonathan K. Alder, Erin M
Paul S. Buckmaster, Megan M. Haney  Epilepsy Research 
Figure Legend: From: High-Fat Diet–Induced Retinal Dysfunction
A B Figure S1. Macroscopic analyses of the ColIITgcog mouse phenotype (female mice) (A) Graph and table of body weights and percentage differences of female.
Volume 21, Issue 2, Pages (October 2017)
Volume 24, Issue 5, Pages (November 2013)
Mark E.J. Sheffield, Michael D. Adoff, Daniel A. Dombeck  Neuron 
Low protein diet mediated renoprotection in remnant kidneys: Renal autoregulatory versus hypertrophic mechanisms  Karen A. Griffin, Maria Picken, Anita.
Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer  Lee.
Isabella Maiellaro, Martin J. Lohse, Robert J. Kittel, Davide Calebiro 
Volume 18, Issue 9, Pages (February 2017)
Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three- Dimensional Ultrasound Imaging Technique  Jie Ni, Paul Cozzi, Tzong-Tyng Hung,
Volume 138, Issue 4, Pages (April 2010)
Volume 96, Issue 5, Pages (March 1999)
Determinants of phosphorus mobilization during hemodialysis
Rhythmic Working Memory Activation in the Human Hippocampus
Volume 25, Issue 3, Pages (March 2017)
Systematic Analysis Reveals that Cancer Mutations Converge on Deregulated Metabolism of Arachidonate and Xenobiotics  Francesco Gatto, Almut Schulze,
Volume 21, Issue 2, Pages (October 2017)
Volume 16, Issue 4, Pages (July 2016)
Defining Resistance and Tolerance to Cancer
Volume 13, Issue 8, Pages (November 2015)
From Static to Dynamic Risk Prediction: Time Is Everything
Volume 8, Issue 2, Pages (July 2014)
Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
The Rate of Increase of Short Telomeres Predicts Longevity in Mammals
Volume 123, Issue 6, Pages (December 2005)
Volume 23, Issue 4, Pages (April 2018)
This Month in Gastroenterology
Periostin Limits Tumor Response to VEGFA Inhibition
Volume 7, Issue 4, Pages (April 2005)
Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age- Related Phenotypes through Telomerase Manipulation  Elsa Vera, Nazario.
Volume 22, Issue 3, Pages (January 2018)
Volume 7, Issue 4, Pages (April 2005)
Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.
Mary Armanios, Jonathan K. Alder, Erin M
A Multi-omic Association Study of Trimethylamine N-Oxide
Volume 14, Issue 11, Pages (March 2016)
Volume 20, Issue 2, Pages (July 2017)
Triple Function of Synaptotagmin 7 Ensures Efficiency of High-Frequency Transmission at Central GABAergic Synapses  Chong Chen, Rachel Satterfield, Samuel.
Volume 22, Issue 18, Pages (September 2012)
Volume 22, Issue 12, Pages (March 2018)
Molecular Therapy - Methods & Clinical Development
Volume 22, Issue 3, Pages (January 2018)
Volume 80, Issue 4, Pages (November 2013)
Volume 16, Issue 4, Pages (October 2012)
Volume 14, Issue 7, Pages (February 2016)
Yoshiaki Yamaguchi, Hitoshi Okamura
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Effects of an intensive weight loss program on knee joint loading in obese adults with knee osteoarthritis  J. Aaboe, H. Bliddal, S.P. Messier, T. Alkjær,
Impaired Dendritic Expression and Plasticity of h-Channels in the fmr1−/y Mouse Model of Fragile X Syndrome  Darrin H. Brager, Arvin R. Akhavan, Daniel.
Ryan G. Natan, Winnie Rao, Maria N. Geffen  Cell Reports 
Preemptive Bone Marrow Transplantation for FANCD1/BRCA2
SIRT1 Is Necessary for Proficient Telomere Elongation and Genomic Stability of Induced Pluripotent Stem Cells  Maria Luigia De Bonis, Sagrario Ortega,
Volume 12, Issue 4, Pages (July 2015)
Casey Brewer, Elizabeth Chu, Mike Chin, Rong Lu  Cell Reports 
Volume 8, Issue 3, Pages (August 2014)
Catalytic activity of mTERT is needed for increased healthspan and life‐span extension in AAV9‐mTERT treated mice.A.Scheme of mTERT‐wt and mTERT‐DN, a.
Volume 16, Issue 11, Pages (September 2016)
Curvilinear relationship between age and assisted reproduction technique success: retrospective analyses of US National ART Surveillance System data from.
Volume 14, Issue 10, Pages (March 2016)
Volume 23, Issue 4, Pages (April 2018)
Volume 66, Issue 4, Pages (October 2004)
Volume 65, Issue 2, Pages (February 2004)
Molecular Therapy - Methods & Clinical Development
Presentation transcript:

The Rate of Increase of Short Telomeres Predicts Longevity in Mammals Elsa Vera, Bruno Bernardes de Jesus, Miguel Foronda, Juana M. Flores, Maria A. Blasco  Cell Reports  Volume 2, Issue 4, Pages 732-737 (October 2012) DOI: 10.1016/j.celrep.2012.08.023 Copyright © 2012 The Authors Terms and Conditions

Figure 1 Mouse Telomeres Shorten 100-Fold Faster than Human Telomeres with Aging (A) Kaplan-Meyer survival curves of the indicated cohorts. Arrows indicate time of blood extraction. (B and C) The mean telomere length (B) and percentage of short telomeres (C) were determined by HT-QFISH on white blood cells (n, number of mice). Values are given as average ± SEM, and statistical significance was determined by one-tailed Student’s t test. (B) From left to right (average ± SEM): 51.49 ± 1.633, 45.10 ± 1.322, 43.18 ± 1.118, 37.51 ± 2.241, 52.61 ± 2.049, 46.06 ± 2.142, 40.54 ± 2.053, 38.55 ± 1.801. (C) From left to right (average ± SEM): 12.78 ± 0.8693, 16.19 ± 0.8230, 17.99 ± 1.257, 25.14 ± 3.552, 12.16 ± 1.078, 16.68 ± 1.237, 20.77 ± 1.798, 21.93 ± 2.581. (D and E) Adjustment of mean telomere length (D) and percentage of short telomeres (E) with aging to a linear or quadratic model. Second-order polynomial adjustment (quadratic) was used for the nonlinear fit model. Cell Reports 2012 2, 732-737DOI: (10.1016/j.celrep.2012.08.023) Copyright © 2012 The Authors Terms and Conditions

Figure 2 The Rate of Increase in the Percentage of Short Telomeres and the Rate of Telomere Shortening Predicts Mouse Longevity (A–C) The percentage of short telomeres (<15 kb; A and C) and mean telomere length (B and C) were determined by HT-QFISH on white blood cells (see Figure 1). Linear regression lines were calculated for the values obtained for the rate of increase in the percentage of short telomeres and for the rate of mean telomere length shortening (kb/month) versus lifespan (weeks). (A) Rate of increase in the percentage of short telomeres (<15 kb) per month versus lifespan (weeks). (B) Rate of mean telomere length shortening (kb/month) versus the rate of increase in the percentage of short telomeres (per month). (C) Rate of mean telomere length shortening (kb/month) versus the rate of increase in the percentage of short telomeres (<15 kb) per month. The slope of each regression line is indicated. See also Figures S1, S2, S3, S4, and S5. Cell Reports 2012 2, 732-737DOI: (10.1016/j.celrep.2012.08.023) Copyright © 2012 The Authors Terms and Conditions

Figure S1 Telomere Length at Different Ages and its Correlation with Longevity, Related to Figure 2 (A) The mean telomere length was determined by HT-QFISH on white blood cells from WT mice at the indicated time points. Linear regression lines were calculated for the values obtained (kb) versus lifespan (weeks). The slope of each regression line is indicated. (B) The percentage of short telomeres (<15 kb) was determined by HT-QFISH on white blood cells from WT mice at the indicated time points. Linear regression lines were calculated for the values obtained (%) versus lifespan (weeks). The slope of each regression line is indicated. Cell Reports 2012 2, 732-737DOI: (10.1016/j.celrep.2012.08.023) Copyright © 2012 The Authors Terms and Conditions

Figure S2 Rate of Increase in the Percentage of Short Telomeres and Rate of Mean Telomere Shortening at Different Age Intervals, Related to Figure 2 (A) The rate of increase in percentage of short telomeres (<15 kb) was determined by HT-QFISH on white blood cells from WT mice at the indicated time points. Values are given as average ± SEM. From left to right (average ± SEM): 0.8719 ± 0.1702, 0.6589 ± 0.3524, 0.5787 ± 0.3407, 0.9236 ± 0.2353, 1.336 ± 0.5503, 0.06455 ± 0.7752. (B) The rate of mean telomere length was determined by HT-QFISH on white blood cells from WT mice at the indicated time points. Values are given as average ± SEM. From left to right (average ± SEM): 1.65 ± 0.4148, 0.74 ± 0.368, 0.4256 ± 0.1863, 1.395 ± 0.4224, 1.71 ± 0.6954, 0.1043 ± 0.6611. Cell Reports 2012 2, 732-737DOI: (10.1016/j.celrep.2012.08.023) Copyright © 2012 The Authors Terms and Conditions

Figure S3 The Rate of Increase in the Percentage of Short Telomeres and the Rate of Telomere Shortening Is a Predictor of Mouse Longevity, Related to Figure 2 (A and B) The rate of increase in percentage of short telomeres (<15 kb; A) and mean telomere length (B) were determined by HT-QFISH on white blood cells from the indicated mice cohorts at the indicated time points (see Figure 1). Linear regression lines were calculated for the values obtained for the rate of increase in the percentage of short telomeres and for the rate of mean telomere length shortening (kb/month) versus lifespan (weeks). (A) Rate of increase in the percentage of short telomeres (<15 kb) per month versus lifespan (weeks). (B) Rate of mean telomere length shortening (kb/month) versus increase in the percentage of short telomeres (per month). Only results from TgTERT mice for which the four time points were measured are plotted. Cell Reports 2012 2, 732-737DOI: (10.1016/j.celrep.2012.08.023) Copyright © 2012 The Authors Terms and Conditions

Figure S4 Correlation between Rates of Telomere Shortening and Weight, Related to Figure 2 (A) Linear regression lines were calculated for the net weight gain of each individual mouse (grams) versus lifespan (weeks). The slope of each regression line is indicated. (B) Linear regression lines were calculated for the net weight gain of each individual mouse (grams) versus the rate of increase in the percentage of short telomere (%/month). The slope of each regression line is indicated. (C) Linear regression lines were calculated for the net weight gain of each individual mouse (grams) versus the rate of mean telomere shortening (kb/month). The slope of each regression line is indicated. Cell Reports 2012 2, 732-737DOI: (10.1016/j.celrep.2012.08.023) Copyright © 2012 The Authors Terms and Conditions

Figure S5 Mice with Faster Rates of Increase in Short Telomeres Present the Same Pathologies, but at an Earlier Onset than Those with Lower Rates of Increase in Short Telomeres, Related to Figure 2 (A) Percentage of WT mice with the indicated tumors or degenerative pathologies at their time of death, belonging to the lower (<0.24%/month) or higher (>0.92%/month) quartiles of the increase in the percentage of short telomeres. The mean lifespan of the different quartiles is also represented. (B) Percentage of TgTERT mice with the indicated tumors or degenerative pathologies at their time of death, belonging to the lower (<0.012%/month) or higher (>0.68%/month) quartiles of the rate of increase in the percentage of short telomeres. The mean lifespan of the different quartiles is also represented. Cell Reports 2012 2, 732-737DOI: (10.1016/j.celrep.2012.08.023) Copyright © 2012 The Authors Terms and Conditions

Cell Reports 2012 2, 732-737DOI: (10.1016/j.celrep.2012.08.023) Copyright © 2012 The Authors Terms and Conditions